News
Eli Lilly (NYSE: LLY) was an unstoppable bet in the past few years, but LLY stock finally started plateauing in the latter ...
14d
Irish Examiner on MSNEli Lilly’s weight-loss drug revenues miss expectations due to lower pricesOn an adjusted basis, Lilly earned $3.34 per share for the quarter, compared with analysts’ estimates of $3.02 per share ...
4d
Stocktwits on MSNMerck, Pfizer, Eli Lilly Stocks Rebound As Trump Targets Drug Costs With New Executive OrderPfizer (PFE), and Eli Lilly (LLY) traded in the green Monday morning despite declining in pre-market hours after President ...
Over the last couple of years, one of the best pharma stocks to own has been Eli Lilly ( LLY -3.19%). But now, an investment in Lilly may not look so enticing as the possibility of more tariffs loom.
U.S.-listed shares of Novo Nordisk plunged 7% in intraday trading Thursday after rival Eli Lilly reported positive oral weight-loss drug news and BMO cut its rating for the Danish drug developer's ...
Eli Lilly's stock boomed April 17 after announcing a new experimental pill that caused nearly 8% weight loss at certain dosages and lowered blood sugar in patients during a clinical trial.
Drugmaker Eli Lilly (LLY ... FDA-approved oral GLP-1 drug, Rybelsus, but its impact on weight loss has been moderate. Orforglipron, being an oral drug, will benefit Lilly in a few ways.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results